The great data transition
Now is the time to adapt how we think about EHR data.
Making the move from claims to EHR data
As the pressure to prove the value of existing and new therapies increases, it’s critical for life sciences firms to leverage additional and more comprehensive data assets.
EHR data is a proven source for gaining additional clinical perspective beyond claims and data sourced from highly controlled clinical trials. Yet resistance to EHR data still exists.
This white paper explores why adoption of EHR data can help researchers better understand patients, the differences between EMR and EHR, and approaches for incorporating such data in research work.
Please complete the form to download the white paper.